Package Leaflet: Information for the User
Apixaban Torrent 5mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
This medicine contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent the formation of blood clots by blocking Factor Xa, an important element in the blood clotting process.
Apixaban is used in adults:
Warnings and precautions
Talk to your doctor, pharmacist, or nurse before taking this medicine if you have any of these conditions:
This medicine will be used with caution in patients with signs of altered liver function
Be careful with Apixaban
If you need to undergo surgery or a procedure that may cause bleeding, your doctor will tell you to temporarily stop taking this medicine for a while. If you are not sure if a procedure may cause bleeding, talk to your doctor.
Children and adolescents
This medicine is not recommended for use in children and adolescents under 18 years of age.
Other medicines and Apixaban Torrent
Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use other medicines.
Some medicines may increase the effects of apixaban, and some medicines may decrease its effects. Your doctor will decide if you should be treated with apixaban if you are taking these medicines and if you should be kept under closer observation.
The following medicines may increase the effects of apixaban and increase the possibility of an unwanted hemorrhage:
The following medicines may reduce the ability of apixaban to prevent blood clot formation:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before taking this medicine.
The effects of apixaban on pregnancy and the fetus are not known. You should not take this medicine if you are pregnant. Tell your doctor immediatelyif you become pregnant while taking this medicine.
It is not known whether apixaban is excreted in human milk. Ask your doctor, pharmacist, or nurse for advice before taking this medicine during breastfeeding. They will tell you whether to stop breastfeeding or whether to stop or not start taking this medicine.
Driving and using machines
Apixaban has no influence on the ability to drive or use machines.
Apixaban Torrent contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Apixaban Torrent contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, talk to your doctor, pharmacist, or nurse.
Dosage
Take the tablet with water. This medicine can be taken with or without food.
Try to take the tablets at the same time each day to achieve a better treatment effect.
If you have difficulty swallowing the tablet whole, talk to your doctor about other possible ways to take apixaban. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.
Instructions for crushing:
If necessary, your doctor may also administer the crushed apixaban tablet mixed in 60 ml of water or 5% glucose in water through a nasogastric tube.
Take Apixaban Torrent according to the following recommendations:
To prevent the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor.
The recommended dose of apixaban is one tabletof apixaban 5mgtwice a day.
The recommended dose is one tabletof apixaban 2.5mgtwice a day if:
The recommended dose is one tablettwice a day, for example, take one tablet in the morning and one in the evening. Your doctor will tell you how long to continue the treatment.
To treat blood clots in the veins of the legs and in the blood vessels of the lungs
The recommended dose is two tabletsof apixaban 5mgtwice a day for the first 7 days, for example, two tablets in the morning and two tablets in the evening.
After 7 days, the recommended dose is one tabletof apixaban 5mgtwice a day, for example, one tablet in the morning and one in the evening.
To prevent blood clots from recurring after 6 months of treatment
The recommended dose is one tabletof apixaban 2.5mgtwice a day, for example, one tablet in the morning and one in the evening.
Your doctor will tell you how long to continue the treatment.
Your doctor may change your anticoagulant treatment as follows:
Stop taking apixaban. Start treatment with anticoagulant medicines (e.g., heparin) at the time you would take the next tablet.
Stop taking anticoagulant medicines. Start treatment with apixabanat the time you would take the next dose of an anticoagulant medicine, and then continue as usual.
Stop taking the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking apixaban.
If your doctor tells you to start taking a medicine that contains a vitamin K antagonist, continue taking apixaban for at least 2 days after your first dose of the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking apixaban.
Patients undergoing cardioversion
If your heartbeat needs to be restored through a process called cardioversion, take this medicine at the times your doctor indicates to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.
If you take more Apixaban than you should
Tell your doctor immediatelyif you have taken a dose greater than the prescribed dose of this medicine. Take the package of the medicine to your doctor, even if there are no tablets left.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you take more apixaban than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse anti-factor Xa activity may be necessary.
If you forget to take Apixaban Torrent
If you have doubts about what to do or if you forget to take more than one dose,ask your doctor, pharmacist, or nurse.
If you stop taking Apixaban Torrent
Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot may be greater if you stop treatment too soon.
If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. The most frequent adverse effect of this medicine is bleeding, which can put the patient's life at risk and requires immediate medical attention.
The following adverse effects have been reported when taking apixaban to prevent the formation of blood clots in the heart in patients with irregular heart rhythm and at least one additional risk factor.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Uncommon Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Very Rare Adverse Effects (may affect up to 1 in 10,000 people)
Frequency Not Known (cannot be estimated from available data)
The following adverse effects have been reported when taking apixaban to treat or prevent blood clots from recurring in the veins of the legs and in the blood vessels of the lungs.
Frequent Adverse Effects (may affect up to 1 in 10 people)
Uncommon Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Frequency Not Known (cannot be estimated from available data)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date stated on the carton and on each blister, after EXP. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Bottles of 60 tablets:
This medicine should not be used after 30 days of first opening.
Bottles of 500 tablets:
This medicine should not be used after 90 days of first opening.
Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of unused medicines. This will help protect the environment.
Composition of Apixaban Torrent
Each tablet contains 5 mg of apixaban.
Appearance of the Product and Package Contents
The 5 mg tablets are pink, oval, biconvex, with beveled edges and "H5" engraved on one face and smooth on the other face.
They are presented in Al-Al blisters within cartons containing 20 or 200 film-coated tablets or in HDPE bottles with child-resistant/continuous thread closure and induction seal containing 60 or 500 film-coated tablets.
Only certain pack sizes may be marketed.
Patient Information Card:
Inside the package of this medicine, along with the leaflet, you will find a Patient Information Card or your doctor may give you a similar card.
This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with apixaban. Always carry this card with you.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Torrent Pharma (Malta) Ltd.
Vault 14, Level 2, Valletta waterfront,
Floriana FRN 1914,
Malta
Manufacturer
Torrent Pharma (Malta) Ltd
Central Business Centre, Level 2,
Triq Hal Tarzien, Il
Gudja GDJ 1907
Malta
Pharmadox Healthcare Ltd.
KW20A Kordin Industrial Park,
Paola, PLA3000,
Malta
Interpharma Services Ltd.
43A Cherni Vrach Blvd,
1407 Sofia,
Bulgaria
Misom Labs Ltd.,
Malta Life Sciences Park,
LS2.01.06, Industrial Estate,
San Gwann, SGN 3000,
Malta
Date of Last Revision of this LeafletMay 2025
Other Sources of Information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/